SpecialtiesQuestion

When, if ever, do you place an intrauterine device in the early post–liver transplant period, and what specific stability criteria do you require before placement?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you decide which patient and with which device to pursue machine perfusion for the organ of a liver transplant recipient?

In DCD liver offers where NRP or hypothermic oxygenated perfusion is available, what donor/recipient factors are still absolute or near-absolute reasons to decline because of ischemic cholangiopathy risk?

In healthy living liver donors with a persistent postoperative bile leak, what leak- and patient- specific thresholds (e.g., drain output trend, biloma size, systemic inflammatory signs, duct anatomy) push you to early ERCP rather than continued percutaneous drainage and observation?

In cirrhosis patients with borderline pre-transplant PVR (≈2–3 WU), what additional findings (e.g., mPAP/TPG, pulmonary artery compliance, RV strain on echo, DLCO) prompt you to treat this as higher risk and arrange closer follow-up or PH-center referral rather than reassuring the transplant team?

Does your working phenotype for ‘new PAH after LT’ (occult POPH vs PAH unmasked after HPS resolution vs distinct post-LT vasculopathy) change what you actually do—specifically, who you screen more aggressively and when you initiate PAH therapy?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.